Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 181

1.

Neuropsychological functions of verbal recall and psychomotor speed significantly affect pain tolerance.

Jacobsen HB, Stubhaug A, Schirmer H, Inge Landrø N, Wilsgaard T, Mathiesen EB, Nielsen CS.

Eur J Pain. 2019 Jul 29. doi: 10.1002/ejp.1437. [Epub ahead of print]

PMID:
31355498
2.

Impact of Chronic Inflammation, Assessed by hs-CRP, on the Association between Red Cell Distribution Width and Arterial Cardiovascular Disease: The Tromsø Study.

Lappegård J, Ellingsen TS, Hindberg K, Mathiesen EB, Njølstad I, Wilsgaard T, Løchen ML, Brækkan SK, Hansen JB.

TH Open. 2018 May 16;2(2):e182-e189. doi: 10.1055/s-0038-1651523. eCollection 2018 Apr.

3.

Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism.

Småbrekke B, Rinde LB, Evensen LH, Morelli VM, Hveem K, Gabrielsen ME, Njølstad I, Mathiesen EB, Rosendaal FR, Braekkan SK, Hansen JB.

J Thromb Haemost. 2019 Aug;17(8):1363-1371. doi: 10.1111/jth.14493. Epub 2019 Jun 7.

PMID:
31124268
4.

Long-term blood pressure trajectories and incident atrial fibrillation in women and men: the Tromsø Study.

Sharashova E, Wilsgaard T, Ball J, Morseth B, Gerdts E, Hopstock LA, Mathiesen EB, Schirmer H, Løchen ML.

Eur Heart J. 2019 May 3. pii: ehz234. doi: 10.1093/eurheartj/ehz234. [Epub ahead of print]

PMID:
31050731
5.

Does insomnia modify the association between C-reactive protein and migraine? The Tromsø Study 2015-2016.

Hagen K, Hopstock LA, Elise Eggen A, Mathiesen EB, Nilsen KB.

Cephalalgia. 2019 Jul;39(8):1022-1029. doi: 10.1177/0333102418825370. Epub 2019 Mar 12.

PMID:
30862180
6.

Effect of prothrombotic genotypes on the risk of venous thromboembolism in patients with and without ischemic stroke. The Tromsø Study.

Rinde LB, Morelli VM, Småbrekke B, Mathiesen EB, Løchen ML, Njølstad I, Wilsgaard T, Smith E, Rosendaal FR, Frazer KA, Braekkan SK, Hansen JB.

J Thromb Haemost. 2019 May;17(5):749-758. doi: 10.1111/jth.14410. Epub 2019 Mar 12.

PMID:
30773804
7.

Effect of Genetically Low 25-Hydroxyvitamin D on Mortality Risk: Mendelian Randomization Analysis in 3 Large European Cohorts.

Aspelund T, Grübler MR, Smith AV, Gudmundsson EF, Keppel M, Cotch MF, Harris TB, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, Mathiesen EB, Njølstad I, Løchen ML, März W, Kleber ME, Tomaschitz A, Grove-Laugesen D, Rejnmark L, Swart KMA, Brouwer IA, Lips P, van Schoor NM, Sempos CT, Durazo-Arvizu RA, Škrabáková Z, Dowling KG, Cashman KD, Kiely M, Pilz S, Gudnason V, Eiriksdottir G.

Nutrients. 2019 Jan 2;11(1). pii: E74. doi: 10.3390/nu11010074.

8.

Gender differences in the association of syndecan-4 with myocardial infarction: The population-based Tromsø Study.

Solbu MD, Kolset SO, Jenssen TG, Wilsgaard T, Løchen ML, Mathiesen EB, Melsom T, Eriksen BO, Reine TM.

Atherosclerosis. 2018 Nov;278:166-173. doi: 10.1016/j.atherosclerosis.2018.08.005. Epub 2018 Sep 15.

PMID:
30278359
9.

Correction: Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration.

Lorenz MW, Gao L, Ziegelbauer K, Norata GD, Empana JP, Schmidtmann I, Lin HJ, McLachlan S, Bokemark L, Ronkainen K, Amato M, Schminke U, Srinivasan SR, Lind L, Okazaki S, Stehouwer CDA, Willeit P, Polak JF, Steinmetz H, Sander D, Poppert H, Desvarieux M, Ikram MA, Johnsen SH, Staub D, Sirtori CR, Iglseder B, Beloqui O, Engström G, Friera A, Rozza F, Xie W, Parraga G, Grigore L, Plichart M, Blankenberg S, Su TC, Schmidt C, Tuomainen TP, Veglia F, Völzke H, Nijpels G, Willeit J, Sacco RL, Franco OH, Uthoff H, Hedblad B, Suarez C, Izzo R, Zhao D, Wannarong T, Catapano A, Ducimetiere P, Espinola-Klein C, Chien KL, Price JF, Bergström G, Kauhanen J, Tremoli E, Dörr M, Berenson G, Kitagawa K, Dekker JM, Kiechl S, Sitzer M, Bickel H, Rundek T, Hofman A, Mathiesen EB, Castelnuovo S, Landecho MF, Rosvall M, Gabriel R, de Luca N, Liu J, Baldassarre D, Kavousi M, de Groot E, Bots ML, Yanez DN, Thompson SG; PROG-IMT study group.

PLoS One. 2018 Sep 20;13(9):e0204633. doi: 10.1371/journal.pone.0204633. eCollection 2018.

10.

The independent and joint associations of physical activity and body mass index with myocardial infarction: The Tromsø Study.

Renninger M, Løchen ML, Ekelund U, Hopstock LA, Jørgensen L, Mathiesen EB, Njølstad I, Schirmer H, Wilsgaard T, Morseth B.

Prev Med. 2018 Nov;116:94-98. doi: 10.1016/j.ypmed.2018.09.005. Epub 2018 Sep 13.

PMID:
30218724
11.

Corrigendum to "Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromsø study" [Atherosclerosis 271 (April 2018) 1-8].

Eltoft A, Arntzen KA, Wilsgaard T, Mathiesen EB, Johnsen SH.

Atherosclerosis. 2018 Oct;277:229. doi: 10.1016/j.atherosclerosis.2018.07.037. Epub 2018 Aug 25. No abstract available.

PMID:
30150082
12.

Recanalisation therapies for wake-up stroke.

Roaldsen MB, Lindekleiv H, Mathiesen EB, Berge E.

Cochrane Database Syst Rev. 2018 Aug 21;8:CD010995. doi: 10.1002/14651858.CD010995.pub2.

13.

The association between red cell distribution width and venous thromboembolism is not explained by myocardial infarction, stroke, or cancer.

Ellingsen TS, Lappegård J, Skjelbakken T, Mathiesen EB, Njølstad I, Brækkan SK, Hansen JB.

Res Pract Thromb Haemost. 2018 Jan 19;2(2):327-333. doi: 10.1002/rth2.12073. eCollection 2018 Apr.

14.

Population distribution of traditional and the emerging cardiovascular risk factors carotid plaque and IMT: the REFINE-Reykjavik study with comparison with the Tromsø study.

Thorsson B, Eiriksdottir G, Sigurdsson S, Gudmundsson EF, Bots ML, Aspelund T, Arntzen KA, Mathiesen EB, Gudnason V.

BMJ Open. 2018 May 31;8(5):e019385. doi: 10.1136/bmjopen-2017-019385.

15.

Fish consumption, fish oil supplements and risk of atherosclerosis in the Tromsø study.

Johnsen SH, Jacobsen BK, Brækkan SK, Hansen JB, Mathiesen EB.

Nutr J. 2018 May 25;17(1):56. doi: 10.1186/s12937-018-0364-8.

16.

Joint Effect of Carotid Plaque and C-Reactive Protein on First-Ever Ischemic Stroke and Myocardial Infarction?

Eltoft A, Arntzen KA, Wilsgaard T, Hansen JB, Mathiesen EB, Johnsen SH.

J Am Heart Assoc. 2018 May 17;7(11). pii: e008951. doi: 10.1161/JAHA.118.008951.

17.

Sex Differences in the Impact of Body Mass Index on the Risk of Future Atrial Fibrillation: Insights From the Longitudinal Population-Based Tromsø Study.

Ball J, Løchen ML, Wilsgaard T, Schirmer H, Hopstock LA, Morseth B, Mathiesen EB, Njølstad I, Tiwari S, Sharashova E.

J Am Heart Assoc. 2018 Apr 19;7(9). pii: e008414. doi: 10.1161/JAHA.117.008414.

18.

The contribution of obesity to carotid atherosclerotic plaque burden in a general population sample in Norway: The Tromsø Study.

Imahori Y, Mathiesen EB, Leon DA, Hopstock LA, Hughes AD, Johnsen SH, Jørgensen L, Emaus N, Morgan KE.

Atherosclerosis. 2018 Jun;273:15-20. doi: 10.1016/j.atherosclerosis.2018.04.014. Epub 2018 Apr 12.

19.

Predictive value for cardiovascular events of common carotid intima media thickness and its rate of change in individuals at high cardiovascular risk - Results from the PROG-IMT collaboration.

Lorenz MW, Gao L, Ziegelbauer K, Norata GD, Empana JP, Schmidtmann I, Lin HJ, McLachlan S, Bokemark L, Ronkainen K, Amato M, Schminke U, Srinivasan SR, Lind L, Okazaki S, Stehouwer CDA, Willeit P, Polak JF, Steinmetz H, Sander D, Poppert H, Desvarieux M, Ikram MA, Johnsen SH, Staub D, Sirtori CR, Iglseder B, Beloqui O, Engström G, Friera A, Rozza F, Xie W, Parraga G, Grigore L, Plichart M, Blankenberg S, Su TC, Schmidt C, Tuomainen TP, Veglia F, Völzke H, Nijpels G, Willeit J, Sacco RL, Franco OH, Uthoff H, Hedblad B, Suarez C, Izzo R, Zhao D, Wannarong T, Catapano A, Ducimetiere P, Espinola-Klein C, Chien KL, Price JF, Bergström G, Kauhanen J, Tremoli E, Dörr M, Berenson G, Kitagawa K, Dekker JM, Kiechl S, Sitzer M, Bickel H, Rundek T, Hofman A, Mathiesen EB, Castelnuovo S, Landecho MF, Rosvall M, Gabriel R, de Luca N, Liu J, Baldassarre D, Kavousi M, de Groot E, Bots ML, Yanez DN, Thompson SG; PROG-IMT study group.

PLoS One. 2018 Apr 12;13(4):e0191172. doi: 10.1371/journal.pone.0191172. eCollection 2018. Erratum in: PLoS One. 2018 Sep 20;13(9):e0204633.

20.

Secondary prevention care and effect: Total and low-density lipoprotein cholesterol levels and lipid-lowering drug use in women and men after incident myocardial infarction - The Tromsø Study 1994-2016.

Hopstock LA, Eggen AE, Løchen ML, Mathiesen EB, Njølstad I, Wilsgaard T.

Eur J Cardiovasc Nurs. 2018 Aug;17(6):563-570. doi: 10.1177/1474515118762541. Epub 2018 Feb 28.

PMID:
29488799
21.

Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Tromsø Study.

Eltoft A, Arntzen KA, Wilsgaard T, Mathiesen EB, Johnsen SH.

Atherosclerosis. 2018 Apr;271:1-8. doi: 10.1016/j.atherosclerosis.2018.02.005. Epub 2018 Feb 7. Erratum in: Atherosclerosis. 2018 Oct;277:229.

PMID:
29453087
22.

Atrial Fibrillation and Cause-Specific Risks of Pulmonary Embolism and Ischemic Stroke.

Hald EM, Rinde LB, Løchen ML, Mathiesen EB, Wilsgaard T, Njølstad I, Brækkan SK, Hansen JB.

J Am Heart Assoc. 2018 Jan 29;7(3). pii: e006502. doi: 10.1161/JAHA.117.006502.

23.

Blood pressure target achievement and antihypertensive medication use in women and men after first-ever myocardial infarction: the Tromsø Study 1994-2016.

Hopstock LA, Eggen AE, Løchen ML, Mathiesen EB, Nilsen A, Njølstad I, Wilsgaard T.

Open Heart. 2018 Jan 3;5(1):e000746. doi: 10.1136/openhrt-2017-000746. eCollection 2018.

24.

Small and large vessel disease in persons with unrecognized compared to recognized myocardial infarction: The Tromsø Study 2007-2008.

Øhrn AM, Schirmer H, von Hanno T, Mathiesen EB, Arntzen KA, Bertelsen G, Njølstad I, Løchen ML, Wilsgaard T, Bairey Merz CN, Lindekleiv H.

Int J Cardiol. 2018 Feb 15;253:14-19. doi: 10.1016/j.ijcard.2017.10.009.

PMID:
29306455
25.

Hypothetical interventions to prevent stroke: an application of the parametric g-formula to a healthy middle-aged population.

Vangen-Lønne AM, Ueda P, Gulayin P, Wilsgaard T, Mathiesen EB, Danaei G.

Eur J Epidemiol. 2018 Jun;33(6):557-566. doi: 10.1007/s10654-017-0344-x. Epub 2018 Jan 2.

PMID:
29294206
26.

Association of occasional smoking with total mortality in the population-based Tromsø study, 2001-2015.

Løchen ML, Gram IT, Mannsverk J, Mathiesen EB, Njølstad I, Schirmer H, Wilsgaard T, Jacobsen BK.

BMJ Open. 2017 Dec 28;7(12):e019107. doi: 10.1136/bmjopen-2017-019107.

27.

Electrocardiographic unrecognized myocardial infarction does not improve prediction of cardiovascular events beyond traditional risk factors. The Tromsø Study.

Øhrn AM, Schirmer H, Njølstad I, Mathiesen EB, Eggen AE, Løchen ML, Wilsgaard T, Lindekleiv H.

Eur J Prev Cardiol. 2018 Jan;25(1):78-86. doi: 10.1177/2047487317736826. Epub 2017 Oct 19.

PMID:
29048217
28.

Repeated measurements of carotid atherosclerosis and future risk of venous thromboembolism: the Tromsø Study.

Småbrekke B, Rinde LB, Hald EM, Njølstad I, Mathiesen EB, Johnsen SH, Hansen JB, Braekkan SK, Lijfering WM.

J Thromb Haemost. 2017 Dec;15(12):2344-2351. doi: 10.1111/jth.13858. Epub 2017 Oct 27.

PMID:
28981216
29.

Atrial fibrillation is associated with cognitive decline in stroke-free subjects: the Tromsø Study.

Tiwari S, Løchen ML, Jacobsen BK, Hopstock LA, Nyrnes A, Njølstad I, Mathiesen EB, Arntzen KA, Ball J, Stewart S, Wilsgaard T, Schirmer H.

Eur J Neurol. 2017 Dec;24(12):1485-1492. doi: 10.1111/ene.13445. Epub 2017 Sep 28.

PMID:
28901674
30.

Longitudinal and secular trends in total cholesterol levels and impact of lipid-lowering drug use among Norwegian women and men born in 1905-1977 in the population-based Tromsø Study 1979-2016.

Hopstock LA, Bønaa KH, Eggen AE, Grimsgaard S, Jacobsen BK, Løchen ML, Mathiesen EB, Njølstad I, Wilsgaard T.

BMJ Open. 2017 Aug 21;7(8):e015001. doi: 10.1136/bmjopen-2016-015001.

31.

C-reactive protein in atherosclerosis - A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study.

Eltoft A, Arntzen KA, Hansen JB, Wilsgaard T, Mathiesen EB, Johnsen SH.

Atherosclerosis. 2017 Aug;263:293-300. doi: 10.1016/j.atherosclerosis.2017.07.001. Epub 2017 Jul 5.

PMID:
28728065
32.

Impact of Venous Thromboembolism on the Formation and Progression of Carotid Atherosclerosis: The Tromsø Study.

Lind C, Småbrekke B, Rinde LB, Hindberg K, Mathiesen EB, Johnsen SH, Arntzen KA, Njølstad I, Lijfering W, Brækkan SK, Hansen JB.

TH Open. 2017 Jun 28;1(1):e66-e72. doi: 10.1055/s-0037-1603983. eCollection 2017 Jun.

33.

Serum osteoprotegerin and renal function in the general population: the Tromsø Study.

Vik A, Brodin EE, Mathiesen EB, Brox J, Jørgensen L, Njølstad I, Brækkan SK, Hansen JB.

Clin Kidney J. 2017 Feb;10(1):38-44. doi: 10.1093/ckj/sfw095. Epub 2016 Oct 3.

34.

Alcohol Consumption and Common Carotid Intima-Media Thickness: The USE-IMT Study.

Britton AR, Grobbee DE, den Ruijter HM, Anderson TJ, Desvarieux M, Engström G, Evans GW, Hedblad B, Kauhanen J, Kurl S, Lonn EM, Mathiesen EB, Polak JF, Price JF, Rembold CM, Rosvall M, Rundek T, Salonen JT, Stehouwer C, Tuomainen TP, Bots ML.

Alcohol Alcohol. 2017 Jul 1;52(4):483-486. doi: 10.1093/alcalc/agx028.

35.

Uric acid predicts mortality and ischaemic stroke in subjects with diastolic dysfunction: the Tromsø Study 1994-2013.

Norvik JV, Schirmer H, Ytrehus K, Storhaug HM, Jenssen TG, Eriksen BO, Mathiesen EB, Løchen ML, Wilsgaard T, Solbu MD.

ESC Heart Fail. 2017 May;4(2):154-161. doi: 10.1002/ehf2.12134. Epub 2017 Jan 31.

36.

Clustering of cardiovascular risk factors and carotid intima-media thickness: The USE-IMT study.

Wang X, Dalmeijer GW, den Ruijter HM, Anderson TJ, Britton AR, Dekker J, Engström G, Evans GW, de Graaf J, Grobbee DE, Hedblad B, Holewijn S, Ikeda A, Kauhanen J, Kitagawa K, Kitamura A, Kurl S, Lonn EM, Lorenz MW, Mathiesen EB, Nijpels G, Okazaki S, Polak JF, Price JF, Rembold CM, Rosvall M, Rundek T, Salonen JT, Sitzer M, Stehouwer CD, Tuomainen TP, Peters SA, Bots ML.

PLoS One. 2017 Mar 21;12(3):e0173393. doi: 10.1371/journal.pone.0173393. eCollection 2017.

37.

Vitamin D and mortality: Individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26916 individuals from a European consortium.

Gaksch M, Jorde R, Grimnes G, Joakimsen R, Schirmer H, Wilsgaard T, Mathiesen EB, Njølstad I, Løchen ML, März W, Kleber ME, Tomaschitz A, Grübler M, Eiriksdottir G, Gudmundsson EF, Harris TB, Cotch MF, Aspelund T, Gudnason V, Rutters F, Beulens JW, van 't Riet E, Nijpels G, Dekker JM, Grove-Laugesen D, Rejnmark L, Busch MA, Mensink GB, Scheidt-Nave C, Thamm M, Swart KM, Brouwer IA, Lips P, van Schoor NM, Sempos CT, Durazo-Arvizu RA, Škrabáková Z, Dowling KG, Cashman KD, Kiely M, Pilz S.

PLoS One. 2017 Feb 16;12(2):e0170791. doi: 10.1371/journal.pone.0170791. eCollection 2017.

38.

Declining Incidence of Ischemic Stroke: What Is the Impact of Changing Risk Factors? The Tromsø Study 1995 to 2012.

Vangen-Lønne AM, Wilsgaard T, Johnsen SH, Løchen ML, Njølstad I, Mathiesen EB.

Stroke. 2017 Mar;48(3):544-550. doi: 10.1161/STROKEAHA.116.014377. Epub 2017 Feb 10.

PMID:
28188260
39.

Myocardial infarction and future risk of cancer in the general population-the Tromsø Study.

Rinde LB, Småbrekke B, Hald EM, Brodin EE, Njølstad I, Mathiesen EB, Løchen ML, Wilsgaard T, Brækkan SK, Vik A, Hansen JB.

Eur J Epidemiol. 2017 Mar;32(3):193-201. doi: 10.1007/s10654-017-0231-5. Epub 2017 Feb 7.

PMID:
28176141
40.

Resting heart rate trajectories and myocardial infarction, atrial fibrillation, ischaemic stroke and death in the general population: The Tromsø Study.

Sharashova E, Wilsgaard T, Løchen ML, Mathiesen EB, Njølstad I, Brenn T.

Eur J Prev Cardiol. 2017 May;24(7):748-759. doi: 10.1177/2047487316688983. Epub 2017 Jan 25.

PMID:
28121181
41.

Magnetic Resonance Volumetry: Prediction of Subjective Memory Complaints and Mild Cognitive Impairment, and Associations with Genetic and Cardiovascular Risk Factors.

Rogne S, Vangberg T, Eldevik P, Wikran G, Mathiesen EB, Schirmer H.

Dement Geriatr Cogn Dis Extra. 2016 Nov 25;6(3):529-540. doi: 10.1159/000450885. eCollection 2016 Sep-Dec.

42.

Macular thickness in healthy eyes of adults (N = 4508) and relation to sex, age and refraction: the Tromsø Eye Study (2007-2008).

von Hanno T, Lade AC, Mathiesen EB, Peto T, Njølstad I, Bertelsen G.

Acta Ophthalmol. 2017 May;95(3):262-269. doi: 10.1111/aos.13337. Epub 2016 Dec 18.

43.

Ischemic Stroke and Risk of Venous Thromboembolism in the General Population: The Tromsø Study.

Rinde LB, Småbrekke B, Mathiesen EB, Løchen ML, Njølstad I, Hald EM, Wilsgaard T, Brækkan SK, Hansen JB.

J Am Heart Assoc. 2016 Nov 7;5(11). pii: e004311.

44.

The Tromsø study 1974-2016: 40 years of cardiovascular research.

Njølstad I, Mathiesen EB, Schirmer H, Thelle DS.

Scand Cardiovasc J. 2016 Oct - Dec;50(5-6):276-281. Epub 2016 Oct 24.

PMID:
27650831
45.

Correction: Genetic Variations in the Vitamin D Receptor Predict Type 2 Diabetes and Myocardial Infarction in a Community-Based Population: The Tromsø Study.

Martinaityte I, Jorde R, Schirmer H, Mathiesen EB, Njølstad I, Løchen ML, Wilsgaard T, Joakimsen RM, Kamycheva E.

PLoS One. 2016 Sep 19;11(9):e0163573. doi: 10.1371/journal.pone.0163573. eCollection 2016.

46.

Atherosclerotic Risk Factors and Risk of Myocardial Infarction and Venous Thromboembolism; Time-Fixed versus Time-Varying Analyses. The Tromsø Study.

Småbrekke B, Rinde LB, Hindberg K, Hald EM, Vik A, Wilsgaard T, Løchen ML, Njølstad I, Mathiesen EB, Hansen JB, Brækkan S.

PLoS One. 2016 Sep 16;11(9):e0163242. doi: 10.1371/journal.pone.0163242. eCollection 2016.

47.

CHA2DS2-VASc score, left atrial size and atrial fibrillation as stroke risk factors in the Tromsø Study.

Tiwari S, Løchen ML, Jacobsen BK, Hopstock LA, Nyrnes A, Njølstad I, Mathiesen EB, Schirmer H.

Open Heart. 2016 Sep 6;3(2):e000439. doi: 10.1136/openhrt-2016-000439. eCollection 2016.

48.

Temporal Trends in Incidence and Case Fatality of Intracerebral Hemorrhage: The Tromsø Study 1995-2012.

Carlsson M, Wilsgaard T, Johnsen SH, Vangen-Lønne AM, Løchen ML, Njølstad I, Mathiesen EB.

Cerebrovasc Dis Extra. 2016;6(2):40-9. doi: 10.1159/000447719. Epub 2016 Aug 13.

49.

Associations Between Common and Rare Exonic Genetic Variants and Serum Levels of 20 Cardiovascular-Related Proteins: The Tromsø Study.

Solomon T, Smith EN, Matsui H, Braekkan SK; INVENT Consortium, Wilsgaard T, Njølstad I, Mathiesen EB, Hansen JB, Frazer KA.

Circ Cardiovasc Genet. 2016 Aug;9(4):375-83. doi: 10.1161/CIRCGENETICS.115.001327. Epub 2016 Jun 21.

50.

C-reactive protein, obesity, and the risk of arterial and venous thrombosis.

Horvei LD, Grimnes G, Hindberg K, Mathiesen EB, Njølstad I, Wilsgaard T, Brox J, Braekkan SK, Hansen JB.

J Thromb Haemost. 2016 Aug;14(8):1561-71. doi: 10.1111/jth.13369. Epub 2016 Jun 22.

Supplemental Content

Loading ...
Support Center